The xDAPT External Validation Study

CompletedOBSERVATIONAL
Enrollment

30,000

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

December 31, 2022

Study Completion Date

December 1, 2024

Conditions
Coronary Artery DiseasePercutaneous Coronary Intervention
Interventions
DEVICE

Percutaneous coronary intervention

Percutaneous coronary intervention (PCI) is a catheter-based technique performed under fluoroscopic guidance to treat coronary artery disease and restore blood flow to the myocardium. During PCI, coronary vessel patency is generally achieved with drug-eluting stents (DES), which are metallic scaffolds coated with a polymer that carry and gradually release an antiproliferative drug. In the present study, all participants underwent PCI with implantation of DES, and received a subsequent course of dual antiplatelet therapy (DAPT), as clinically indicated.

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT06736626 - The xDAPT External Validation Study | Biotech Hunter | Biotech Hunter